|Articles|November 1, 1998

November 1998
Volume 4
Issue 11

Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

Download PDF: Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

Articles in this issue

over 27 years ago

Article

Discontinuity of Care: Urgent Care Utilization Within a Health Maintenance Organization

over 27 years ago

Article

Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

over 27 years ago

Article

The Ethical Dilemma of Population-Based Medical Decision Making

over 27 years ago

Article

Efficacy, Safety, and Impact on Quality of Life of Salmeterol in Patients With Moderate Persistent Asthma

over 27 years ago

Article

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

over 27 years ago

Article

Ventricular Arrhythmias and the Use of Antiarrhythmic Drugs After Cardiovascular Surgery

over 27 years ago

Article

Methods of Evaluation in Outcomes Research

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis

Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course

Small Workflow Changes Close Big Gaps in CKM Screening

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%